HSD17B1 and Alzheimer disease: We found that, compared with the control group, the gene expression levels of STAR, HSD17B1, CYP19A1, and HSD3B2 in both OE and AD groups were all significantly elevated (all P-values ≤ 0.023; Fig. 5A–D), especially OE lesions.